Why Palantir Stock Is Up Today
The Centers for Disease Control and Prevention (CDC) has renewed a software agreement with Palantir Technologies (NYSE: PLTR), awarding the tech company a new five-year, $443 million contract. Investors are applauding the deal, sending shares of Palantir up as much as 5% on Wednesday. Palantir provides data analytics tools for government and commercial customers.